Is sublingual nitroglycerin contraindicated in a patient with an anterior wall myocardial infarction who has taken a phosphodiesterase‑5 inhibitor (e.g., sildenafil, tadalafil, vardenafil) within the past 24 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sublingual Nitroglycerin is Absolutely Contraindicated with Recent Phosphodiesterase-5 Inhibitor Use

Sublingual nitroglycerin should NOT be administered to a patient with an anterior wall myocardial infarction (or any MI) who has taken a phosphodiesterase-5 inhibitor within the specified timeframes: 24 hours for sildenafil or vardenafil, or 48 hours for tadalafil. This is a Class III contraindication (meaning it may cause harm) regardless of the MI location 1, 2, 3.

The Critical Contraindication: PDE-5 Inhibitors

The contraindication is based on the drug interaction between nitrates and PDE-5 inhibitors, NOT the location of the MI. Here's the algorithmic approach:

Timing-Based Contraindications for Nitrate Administration:

Absolute contraindications based on PDE-5 inhibitor timing:

  • Sildenafil: Do not give nitrates within 24 hours of last dose 1, 2, 4
  • Tadalafil: Do not give nitrates within 48 hours of last dose 1, 2, 4, 5
  • Vardenafil: Timing not definitively established in guidelines, but 24 hours is recommended based on pharmacology 1, 2
  • Avanafil: Do not give nitrates within 12 hours 6

Why This Interaction is Dangerous:

PDE-5 inhibitors block the enzyme that degrades cyclic GMP, which mediates nitric oxide-induced vasodilation. When combined with nitrates (which release nitric oxide), the result is profound, prolonged, and potentially life-threatening hypotension 2, 1. This interaction has been associated with myocardial infarction and death 2, 1, 7.

The hemodynamic data is striking:

  • Sildenafil + nitroglycerin: mean maximal standing BP drops of -36/-21 mmHg compared to -26/-12 mmHg with placebo 7
  • Tadalafil + nitroglycerin: standing systolic BP fell below 85 mmHg in significantly more patients at 4,8, and 24 hours post-tadalafil 8
  • The interaction with tadalafil persists for 24 hours but dissipates by 48 hours 8, 9

The Anterior Wall MI is NOT the Contraindication

Common pitfall: Confusing the PDE-5 inhibitor contraindication with the right ventricular (RV) infarction contraindication. These are separate issues:

Other Nitrate Contraindications (Unrelated to PDE-5 Inhibitors):

  1. Hypotension: Systolic BP <90 mmHg or ≥30 mmHg below baseline 1, 10, 1, 2, 4
  2. Severe bradycardia: Heart rate <50 bpm 1, 2
  3. Tachycardia without heart failure: Heart rate >100 bpm 1, 2
  4. Right ventricular infarction (typically with inferior MI, not anterior) 1, 10, 1, 2, 4

Anterior wall MI itself is NOT a contraindication to nitrates - the location doesn't matter unless there's associated RV involvement or hemodynamic instability.

Clinical Decision Algorithm:

Before giving sublingual nitroglycerin to ANY MI patient:

  1. Check medication history for PDE-5 inhibitors

    • If sildenafil/vardenafil within 24 hours → STOP, contraindicated
    • If tadalafil within 48 hours → STOP, contraindicated
    • If avanafil within 12 hours → STOP, contraindicated
  2. Check hemodynamics

    • Systolic BP <90 mmHg or drop ≥30 mmHg → contraindicated
    • Heart rate <50 or >100 (without HF) → contraindicated
  3. Assess for RV involvement (especially with inferior MI)

    • Look for ST elevation in V4R, hypotension with clear lungs, JVD
    • If RV infarction suspected → contraindicated
  4. If all checks pass → May give up to 3 doses of 0.4 mg sublingual NTG every 5 minutes 10, 4, 6

Emergency Situations:

If nitrates are deemed medically necessary in a life-threatening situation after tadalafil use, the FDA drug label states that at least 48 hours should elapse, and nitrates should only be given under close medical supervision with hemodynamic monitoring 5. However, the guideline evidence classifies this as a contraindication without exception 1, 2.

The most recent 2025 ACC/AHA guidelines reinforce these timing restrictions explicitly 6, maintaining consistency with the FDA labeling 3, 5, 11.

References

Research

Time course of the interaction between tadalafil and nitrates.

Journal of the American College of Cardiology, 2003

Research

Cardiovascular effects of tadalafil.

The American journal of cardiology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.